Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-009043
Filing Date
2024-11-25
Accepted
2024-11-25 16:10:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4041
  Complete submission text file 0001950047-24-009043.txt   5567
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Subject) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-50633 | Film No.: 241495976
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12790 EL CAMINO REAL C/O NEUROCRINE BIOSCIENCES SAN DIEGO CA 92130
Business Address
WIERENGA WENDALL (Reporting) CIK: 0001235945 (see all company filings)

Type: 144